Zimbabwe has declined a substantial American health deal valued at $367m (£272m) spanning five years over the United States' insistence on confidential biological samples.
The decision was revealed after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
An official representative has since explained that the United States was requesting health data for research and profit but was unwilling to share the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued dialogue to secure a agreement suitable to both sides so the country's critical HIV treatment initiative can continue.
Broader Background
This development comes after a comparable case in Kenya, where a court suspended a related deal with the US following legal challenges were filed about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.
Based on statements, Sixteen African countries have so far agreed to similar agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our people if a future pandemic emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks already set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further discussions with our US partners on how subsequent co-operation could be structured in a way that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that negotiations must proceed since a large portion of the country's Aids initiatives relied on external financing.
"If specific concerns arise, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group said.
The situation emphasises the continuing debate between receiving vital international aid and protecting local interests in an ever more interconnected world.